Evaluating the "typical" cardiometabolic patient for risk of cardiovascular disease.
Strobl
David J
DJ
D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy; D003131:Combined Modality Therapy; D004032:Diet; D004359:Drug Therapy, Combination; D015444:Exercise; D005500:Follow-Up Studies; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000175:diagnosis; D006949:Hyperlipidemias / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D008019:Life Style; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D018570:Risk Assessment; D016896:Treatment Outcome